Annual Report 2024

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2024 142 The United Laboratories International Holdings Limited Annual Report 2024 39. FINANCIAL INSTRUMENTS (Continued) Financial risk management objectives and policies (Continued) Liquidity risk (Continued) Weighted On demand 3 months Total average or less than 1-3 to 1-5 undiscounted Carrying interest rate 1 month months 1 year years cash flows amount % RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 At 31 December 2023 Trade and other payables – 719,487 2,699,056 1,333,917 – 4,752,460 4,752,460 Borrowings – floating-rate 2.86 177,220 6,440 29,518 1,438,106 1,651,284 1,473,000 – fixed-rate 1.40 3,474 15,079 5,463 – 24,016 23,853 Lease liabilities 5.40 1,075 1,420 2,248 6,312 11,055 6,831 901,256 2,721,995 1,371,146 1,444,418 6,438,815 6,256,144 Derivative – net settlement Foreign currency forward contracts 2.71 2,139 4,278 19,250 21,389 47,056 44,778 The table below summarises the maturity analysis of term loans of RMB270,000,000 (2023: RMB80,000,000) with a repayment on demand clause based on the agreed scheduled repayments set out in the loan agreements at 31 December 2024. The amounts include interest payments computed using the specified fixed rates or variable rates. As a result, these amounts are greater than the amounts disclosed in the “on demand” time band in the maturity analysis above. Taking into account the Group’s financial position, the directors of the Company do not consider that it is probable that the banks will exercise its discretion to demand immediate repayment. The directors of the Company believe that such term loans will be repaid in accordance with the scheduled repayment dates set out in the loan agreements. Maturity Analysis – Bank loans with a repayment on demand clause based on scheduled repayments Total Less than 3 months to undiscounted Carrying 1 month 1-3 months 1 year cash outflows amount RMB’000 RMB’000 RMB’000 RMB’000 RMB’000 31 December 2024 630 1,260 270,000 271,890 270,000 31 December 2023 240 480 80,720 81,440 80,000 The amounts included above for variable interest rate instruments for non-derivative financial liabilities is subject to change if changes in variable interest rates differ to those estimates of interest rates determined at the end of the reporting period.